selpercatinib
eli lilly
['solid tumor', 'selpercatinib', 'libretto-001']
 so honored to present the latest tumor agnostic efficacy of selpercatinib in patients with ret fusion+ solid tumors: a global, multicenter, registrational trial update (libretto-001) #asco22 ! #precisionmedicine 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.